(Reuters Health) - The new anti-tuberculosis drug combination of bedaquiline, pretomanid and linezolid cures 90% of people with deadly drug-resistant TB if given for six months, researchers report in The New England Journal of Medicine. “This is extremely ...
from Google Alert - health https://ift.tt/2uYs9kG
via IFTTT
0 comments:
Post a Comment